|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
18.340 -0.100 (-0.542%) Ranking Overview
Ranking based on 13 research report(s)
Average Ranking 2.23
|
Strong Buy (1)
0
|
Buy (2)
11
|
Hold (3)
1
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 226.00 RMB (cts) | |
| Net Profit | 7,049.68 RMB (MIL) | DPS | 68.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 8,058.00 | 258.00 | 73.52 | -- | 9,082.00 | 6,951.40 |
| 2026 | 8,504.00 | 273.00 | 80.00 | -- | 9,984.00 | 7,200.80 |
| 2027 | 9,114.50 | 292.00 | 87.50 | -- | 10,179.00 | 7,643.70 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 9,082.00 | 291.00 | -- | CITIC SEC | Buy | 27.00 | 16/03/2025 | |
| 2025 | 7,475.00 | 240.00 | 72.00 | CICC | OutPerform | 24.70 | 26/03/2025 | |
| 2025 | 8,067.00 | 258.00 | 78.00 | UBS | Buy | 24.50 | 25/03/2025 | |
| 2025 | 8,411.00 | 269.90 | 80.90 | CITIGROUP | Buy | 24.20 | 24/03/2025 | |
| 2025 | 8,590.00 | 275.00 | 82.27 | MORGAN STANLEY | Overweight | 24.00 | 24/03/2025 | |
| 2025 | 7,432.00 | 238.00 | 71.00 | FIRST SHANGHAI SEC | Buy | 23.96 | 28/03/2025 | |
| 2025 | 9,032.00 | 289.00 | -- | BANK OF AMERICA | Buy | 23.50 | 15/01/2025 | |
| 2025 | 8,058.00 | 259.00 | -- | NOMURA | Buy | 23.40 | 24/03/2025 | |
| 2025 | 7,621.00 | 244.00 | 73.52 | HUATAI FIN HLDGS HK | Buy | 22.54 | 01/04/2025 | |
| 2025 | 8,779.00 | 281.30 | 84.70 | DAIWA | OutPerform | 21.00 | 24/03/2025 | |
| 2025 | 7,551.00 | 242.00 | 72.80 | CLSA | OutPerform | 20.00 | 24/03/2025 | |
| 2025 | 7,843.00 | 251.00 | 75.00 | HSBC | Hold | 18.00 | 28/03/2025 | |
| 2025 | 6,951.40 | 223.00 | 66.29 | UOB | Sell | 16.50 | 25/03/2025 | |
| 2026 | 9,896.00 | 317.00 | -- | CITIC SEC | -- | -- | 16/03/2025 | |
| 2026 | 7,926.00 | 254.00 | 76.00 | CICC | -- | -- | 26/03/2025 | |
| 2026 | 8,504.00 | 273.00 | 82.00 | UBS | -- | -- | 25/03/2025 | |
| 2026 | 9,164.00 | 294.00 | 88.20 | CITIGROUP | -- | -- | 24/03/2025 | |
| 2026 | 8,985.00 | 288.00 | 85.85 | MORGAN STANLEY | -- | -- | 24/03/2025 | |
| 2026 | 7,558.00 | 242.00 | 73.00 | FIRST SHANGHAI SEC | -- | -- | 28/03/2025 | |
| 2026 | 9,984.00 | 320.00 | -- | BANK OF AMERICA | -- | -- | 15/01/2025 | |
| 2026 | 9,078.00 | 291.00 | -- | NOMURA | -- | -- | 24/03/2025 | |
| 2026 | 8,167.00 | 262.00 | 78.76 | HUATAI FIN HLDGS HK | -- | -- | 01/04/2025 | |
| 2026 | 9,494.00 | 304.20 | 91.60 | DAIWA | -- | -- | 24/03/2025 | |
| 2026 | 8,475.00 | 271.60 | 81.80 | CLSA | -- | -- | 24/03/2025 | |
| 2026 | 8,340.00 | 267.00 | 80.00 | HSBC | -- | -- | 28/03/2025 | |
| 2026 | 7,200.80 | 231.00 | 69.78 | UOB | -- | -- | 25/03/2025 | |
| 2027 | 9,252.00 | 296.00 | 89.00 | UBS | -- | -- | 25/03/2025 | |
| 2027 | 9,925.00 | 318.40 | 95.50 | CITIGROUP | -- | -- | 24/03/2025 | |
| 2027 | 7,717.00 | 247.00 | 74.00 | FIRST SHANGHAI SEC | -- | -- | 28/03/2025 | |
| 2027 | 8,660.00 | 278.00 | 83.66 | HUATAI FIN HLDGS HK | -- | -- | 01/04/2025 | |
| 2027 | 10,179.00 | 326.20 | 98.20 | DAIWA | -- | -- | 24/03/2025 | |
| 2027 | 9,746.00 | 312.30 | 94.00 | CLSA | -- | -- | 24/03/2025 | |
| 2027 | 8,977.00 | 288.00 | 86.00 | HSBC | -- | -- | 28/03/2025 | |
| 2027 | 7,643.70 | 245.00 | 73.26 | UOB | -- | -- | 25/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 30/04/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 7,049,683 |
| %Change | -22.135% |
| EPS / (LPS) | RMB 2.260 |
| NBV Per Share (¥) | RMB 25.278 |